Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure

Part of paid clinical trials in Denver, Colorado.

Sponsor
Johns Hopkins University
Study ID
NCT07805811
Phase
PHASE2
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • HEROIC program — BEHAVIORAL
    The HEart Failure Resilience Intervention for Caregivers (HEROIC) is a theory- and evidence-based primary palliative care intervention including 5 individualized nurse-led sessions conducted over 10 weeks via video calls. HEROIC helps caregivers identify and address caregiving and palliative care needs for the patient, while also focusing on caregiver mental health, leveraging multi-level resilience resources: individual (goal-setting, self-care), community (social support, palliative/clinical, community) and existential (life purpose).
  • Active Comparator Control 1 — BEHAVIORAL
    The control group will receive: 1. Written materials with resources from organizations such as the National Alliance on Caregiving, the Heart Failure Society of America and International Society for Heart \& Lung Transplantation (ISHLT) (patient and family education); 2. Home safety tips for caregivers developed by the National Institute on Aging; and 3. A monthly newsletter highlighting a heart healthy recipe, a self-care behavior such as getting adequate sleep, and one clinical or community resource; and 4. Bi-weekly check-in calls to discuss heart failure disease education and home safety tips.

Study Details

This study will test the mechanisms of a multi-component, nurse-led, primary palliative care intervention, HEart failure Resilience Intervention for Caregivers (HEROIC) to improve caregiver mental well-being, patient health-related quality of life and unplanned acute care in the setting of advanced heart failure. The investigators will conduct a multi-site, randomized controlled trial to test proposed mechanisms of action in a large sample (N=500) of persons with heart failure and the caregivers. The investigators will also examine variation in response to HEROIC components by heart failure subgroup (ventricular assist device, heart transplant or medically managed heart failure).

Key Dates

First listed
Sep 4, 2026
Start date
Jan 4, 2027
Status verified
Sep 2026
Primary completion
Nov 30, 2030
Completion
Mar 31, 2031

Study Design

Enrollment
500 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: HEROIC program
    The HEart Failure Resilience Intervention for Caregivers (HEROIC) is a theory- and evidence-based primary palliative care intervention including 5 individualized nurse-led sessions conducted over 10 weeks via video calls. HEROIC helps caregivers identify and address caregiving and palliative care needs for the patient, while also focusing on caregiver mental health, leveraging multi-level resilience resources: individual (goal-setting, self-care), community (social support, palliative/clinical, community) and existential (life purpose).
  • Active Comparator: Control condition
    The control group will receive written educational materials related to Heart Failure (HF) management, home safety tips, and supportive resources. This control is selected to provide a comparative baseline that reflects typical care practices without the active intervention elements .

Primary Outcome Measure

Mental Health (caregiver) as assessed by the Short Form Health Survey (SF-36) [ Time Frame: 12 weeks ]

Central Contacts

  • Martha Abshire Saylor, Principal Investigator, PhD, RN
    HEROIC phone number
  • Meagan Clemence, Study Coordinator, M.Ed

Locations (2)

FacilityCityStateZIPSite coordinators
University of Colorado AnschutzDenverColorado80217
Colleen McIlvennan,, PhD, DNP, ANP
920-540-0809
Johns Hopkins University, School of NursingBaltimoreMaryland21205
Martha Abshire Saylor, PhD
443-340-6201
Martha Abshire Saylor, PhD (PRINCIPAL_INVESTIGATOR)
Colleen McIlvennan, PhD, DNP, ANP (SUB_INVESTIGATOR)

Find similar trials in Denver, CO

By condition

Related Studies